ATNM
Actinium Pharmaceuticals Inc
1.20$
-1.6%
vs. previous close
Closing price · As of: Sep 21, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| – | – | – | – | – | – | 71.9% | 45.8% | 67.9% | 975.3% | – | – | |
| – | – | – | – | – | – | -71.9% | 54.2% | 100.0% | 100.0% | – | 100.0% | |
| – | – | – | – | – | – | 2,586.0% | 1,530.3% | 2,246.1% | 47,740.7% | – | 23,471.1% | |
| – | – | – | – | – | – | 1,014.1% | 706.0% | 1,165.0% | 16,458.0% | – | 16,903.3% | |
| – | – | – | – | – | – | 3,528.3% | 2,236.4% | 3,411.1% | 64,198.8% | – | 40,374.4% | |
| – | – | – | – | – | – | -3,600.2% | -2,182.2% | -3,311.1% | -64,098.8% | – | -40,274.4% | |
| – | – | – | – | – | – | 0.0% | 16.6% | 105.5% | – | – | – | |
| – | – | – | – | – | – | -3,571.5% | -2,165.6% | -3,205.5% | -60,269.1% | – | -37,652.2% | |
| – | – | – | – | – | – | -28.6% | -16.6% | -105.5% | 768.0% | – | – | |
| – | – | – | – | – | – | -3,571.5% | -2,165.6% | -3,205.5% | -60,269.1% | – | -37,652.2% | |
| – | – | – | – | – | – | -3,499.7% | -2,119.8% | -3,137.7% | -59,293.8% | – | -36,740.0% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.